VolitionRx announces offering of common stock and warrants, no amount given

VolitionRx (VNRX) Limited announced that it is proposing to offer and sell, in an underwritten public offering, shares of its common stock and accompanying common stock purchase warrants. All of the securities in the offering are being offered by Volition. Volition intends to use the net proceeds from the offering for research and continued product development, clinical studies, product commercialization, working capital and other general corporate purposes, including potential strategic acquisitions. Newbridge Securities Corporation is acting as the sole book-running manager of the proposed offering.